Events Partner Content TCR-based Therapeutics for Solid Tumors Summit Hear from experts at the TCR based Therapeutics Summit
Events Partner Content Multi-Functional Cell Therapies Summit Development with Next-Generation Cell Therapies
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
